REGN4461 (Mibavademab) for Lipodystrophy in 7MM: Market Size, Sales, Forecasts, and Emerging Insights 2019-2023, 2024-2032
30. April 2024 04:31 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "REGN4461 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Lipodystrophy - Unveiling the Future: A Comprehensive Epidemiology Forecast Report to 2032
04. August 2023 07:48 ET
|
Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Lipodystrophy Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report provides an...
Lipodystrophy - Market Insight, Epidemiology And Market Forecast 2023-2032: Robust Pipeline With Novel MOA and Oral ROA, Increasing Prevalence, and Effectiveness of Drugs Drives Market
22. Februar 2023 08:08 ET
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Lipodystrophy - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This...